Page last updated: 2024-10-30

lorazepam and Stiff-Person Syndrome

lorazepam has been researched along with Stiff-Person Syndrome in 1 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Stiff-Person Syndrome: A condition characterized by persistent spasms (SPASM) involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. (Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51(1):85-93)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teggi, R1
Piccioni, LO1
Martino, G1
Bellini, C1
Bussi, M1

Reviews

1 review available for lorazepam and Stiff-Person Syndrome

ArticleYear
Stiff-person syndrome with acute recurrent peripheral vertigo: possible evidence of gamma aminobutyric acid as a neurotransmitter in the vestibular periphery.
    The Journal of laryngology and otology, 2008, Volume: 122, Issue:6

    Topics: Autoantibodies; Electromyography; GABA Agents; GABA Modulators; gamma-Aminobutyric Acid; Humans; Lor

2008